Good point. I look back at my impressions during the scientific discussions. I was struck by the enthusiasm of the presenters for leronlimab. It seemed to have more credibility coming from the investigator's lips rather than a sales rep.

Also heard some pretty impressive data that I've not been aware of..in all the presentations. We've all heard bits and pieces of information but not in this detailed format. I also agree with many here that the presentation seemed to be directed to the scientific/medical community.

Disappointed in the timelines but impressed with the team in the trenches.

I'm hanging in there.